Waratah Capital Advisors’s Humana HUM Stock Holding History

Waratah Capital Advisors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,500	Closed	-$2.6M	–	152
2024 Q1	$2.6M	Buy	+7,500	New	+$2.84M	0.08%	102

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Waratah Capital Advisors's HUM Position: Q1 2024 in Review

Waratah Capital Advisors sold out of Humana (HUM) in Q1 2024, closing a stake of 8,808 shares — an estimated $3.34M sold.

Waratah Capital Advisors first reported a position in HUM in Q3 2023 and held it in 2 quarters. The position peaked at $4.03M in Q4 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

Waratah Capital Advisors reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
Waratah Capital Advisors sold 8,808 Humana shares in Q1 2024, an estimated $3.34M.
Waratah Capital Advisors first reported a position in Humana in Q3 2023 and held it in 2 quarters.
Waratah Capital Advisors's Humana position peaked at $4.03M in Q4 2023.
1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Waratah Capital Advisors's 13F filing for Q1 2024, filed 14 May 2024.